Chinese and Russian manufacturers are seeing growing appetite from foreign buyers for their Covid-19 vaccines as the international scramble for jabs intensifies, despite lingering concerns over incomplete trial data and the rigour of domestic approval processes.
随着各国对新冠疫苗争夺加剧，manbetx3.0 和俄罗斯制造商看到外国买家对其新冠疫苗的兴趣越来越大，尽管外界对试验数据不完整和国内审批程序严谨程度的担忧挥之不去。
您已阅读4%（336字），剩余96%（8134字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。